Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for Nocturia (DAISS)
NCT01779466Phase 2Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desmopressin in nocturia, sponsored by Ferring Pharmaceuticals. Started Apr 2013; status: terminated.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01779466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779466.